Your browser doesn't support javascript.
loading
Cerebral Small Vessel Disease Burden Is Increased in Systemic Lupus Erythematosus.
Wiseman, Stewart J; Bastin, Mark E; Jardine, Charlotte L; Barclay, Gayle; Hamilton, Iona F; Sandeman, Elaine; Hunt, David; Amft, E Nicole; Thomson, Susan; Belch, Jill F F; Ralston, Stuart H; Wardlaw, Joanna M.
Afiliação
  • Wiseman SJ; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Bastin ME; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Jardine CL; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Barclay G; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Hamilton IF; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Sandeman E; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Hunt D; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Amft EN; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Thomson S; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Belch JF; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Ralston SH; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
  • Wardlaw JM; From the Centre for Clinical Brain Sciences (S.J.W., M.E.B., C.L.J., G.B., I.F.H., E.S., D.H., J.M.W.) and Centre for Genomic and Experimental Medicine (S.H.R.), University of Edinburgh, United Kingdom; Department of Rheumatology, Western General Hospital, Edinburgh, United Kingdom (E.N.A.); and Div
Stroke ; 47(11): 2722-2728, 2016 11.
Article em En | MEDLINE | ID: mdl-27703087
ABSTRACT
BACKGROUND AND

PURPOSE:

Systemic lupus erythematosus (SLE) increases stroke risk, but the mechanism is uncertain. This study aimed to determine the association between SLE and features on neuroimaging of cerebral small vessel disease (SVD), a risk factor for stroke.

METHODS:

Consecutive patients attending a clinic for SLE were recruited. All patients underwent brain magnetic resonance imaging; had blood samples taken for markers of inflammation, endothelial dysfunction, cholesterol, and autoantibodies; and underwent cognitive and psychiatric testing. The data were compared with sex- and age-matched healthy controls and patients with minor stroke. Features of SVD were measured, a total SVD score calculated, and associations sought with vascular risk factors, cognition, SLE activity, and disease duration.

RESULTS:

Fifty-one SLE patients (age 48.8 years; SD 14.3 years) had a greater total SVD score compared with healthy controls (1 versus 0; P<0.0001) and stroke patients (1 versus 0; P=0.02). There were higher perivascular spaces and deep white matter hyperintensity scores and more superficial brain atrophy in SLE patients versus healthy controls. Despite fewer vascular risk factors than similarly aged stroke patients, SLE patients had similar or more of some SVD features. The total SVD score was not associated with SLE activity, cognition, disease duration, or any blood measure.

CONCLUSIONS:

In this data set, SLE patients had a high burden of SVD features on magnetic resonance imaging, particularly perivascular spaces. A larger longitudinal study is warranted to determine the causes of SVD features in SLE and clinical implications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Acidente Vascular Cerebral / Doenças de Pequenos Vasos Cerebrais / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Índice de Gravidade de Doença / Acidente Vascular Cerebral / Doenças de Pequenos Vasos Cerebrais / Lúpus Eritematoso Sistêmico Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2016 Tipo de documento: Article